Compare FATE & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FATE | CCLD |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | N/A | 3650 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.6M | 114.0M |
| IPO Year | 2013 | N/A |
| Metric | FATE | CCLD |
|---|---|---|
| Price | $1.25 | $2.98 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.10 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 510.3K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.88 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,646,000.00 | N/A |
| Revenue This Year | N/A | $11.49 |
| Revenue Next Year | N/A | $7.95 |
| P/E Ratio | ★ N/A | $32.04 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.91 | $1.73 |
| 52 Week High | $1.94 | $4.01 |
| Indicator | FATE | CCLD |
|---|---|---|
| Relative Strength Index (RSI) | 46.34 | 46.01 |
| Support Level | $0.95 | $2.88 |
| Resistance Level | $1.30 | $3.14 |
| Average True Range (ATR) | 0.08 | 0.16 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 14.89 | 51.51 |
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.